Сложности ведения пациента с гемофилией А и анафилактическими реакциями на препараты фактора VIII и препараты шунтирующего действия

1. Warrier I., Lusher J.M. Development of anaphylactic shock in haemophilia B patients with inhibitors. Blood Coagul Fibrinolysis 1998;9 Suppl 1:S125–8. PMID: 9819043.

2. Montalvão S.A.L., Tucunduva A.C., Siqueira L.H., Sambo A.L.A., Medina S.S., Ozelo M.C. Allergic reaction in a cohort of haemophilia A patients using plasma‐derived factor VIII (FVIII) concentrate is rare and not necessarily triggered by FVIII. Haemophilia 2015;21:e281–5. doi:10.1111/hae.12647.

3. Clapp R., Green D. Reaction to rapidly infused AHF cryoprecipitate. N Engl J Med 1969;281(6):329. doi: 10.1056/nejm196908072810617.

4. Erskine J.G., Davidson J.F. Anaphylactic reaction to low-molecular-weight porcine factor VIII concentrates. Br Med J (Clin Res Ed) 1981;282(6281):2011–2. doi: 10.1136/bmj.282.6281.2011-a.

5. Bove J.R., McIntosh S. Anaphylactic reaction to purifi ed anti-hemophilic factor concentrate. Transfusion 1988;28(6):603. doi: 10.1046/j.1537-2995.1988.28689059042.x.

6. Shopnick R., Kazemi M., Brettler D., Buckwalter C., Yang L., Bray G., Gomperts E. Anaphylaxis after treatment with recombinant factor VIII. Transfusion 1996;36:358–61. doi:10.1046/j.1537-2995.1996.36496226153.x.

7. Levy-Mendelovich S., Livnat T., Barg A.A., Kidon M., Brutman-Barazani T., Kenet G. Allergy and inhibitors in hemophilia - a rare complication with potential novel solutions. Blood Cells Mol Dis 2020;80:102370. doi: 10.1016/j.bcmd.2019.102370.